These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 24874546)

  • 21. Distinct functional alterations in SCN8A epilepsy mutant channels.
    Pan Y; Cummins TR
    J Physiol; 2020 Jan; 598(2):381-401. PubMed ID: 31715021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. R1617Q epilepsy mutation slows Na
    Poulin H; Chahine M
    J Physiol; 2021 Mar; 599(5):1651-1664. PubMed ID: 33442870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A SCN8A variant associated with severe early onset epilepsy and developmental delay: Loss- or gain-of-function?
    Liu Y; Koko M; Lerche H
    Epilepsy Res; 2021 Dec; 178():106824. PubMed ID: 34847423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SCN8A epileptic encephalopathy mutations display a gain-of-function phenotype and divergent sensitivity to antiepileptic drugs.
    Guo QB; Zhan L; Xu HY; Gao ZB; Zheng YM
    Acta Pharmacol Sin; 2022 Dec; 43(12):3139-3148. PubMed ID: 35902765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A de novo SCN8A heterozygous mutation in a child with epileptic encephalopathy: a case report.
    Lin KM; Su G; Wang F; Zhang X; Wang Y; Ren J; Wang X; Yao Y; Zhou Y
    BMC Pediatr; 2019 Nov; 19(1):400. PubMed ID: 31672125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical study of 19 patients with SCN8A-related epilepsy: Two modes of onset regarding EEG and seizures.
    Denis J; Villeneuve N; Cacciagli P; Mignon-Ravix C; Lacoste C; Lefranc J; Napuri S; Damaj L; Villega F; Pedespan JM; Moutton S; Mignot C; Doummar D; Lion-François L; Gataullina S; Dulac O; Martin M; Gueden S; Lesca G; Julia S; Cances C; Journel H; Altuzarra C; Ben Zeev B; Afenjar A; Barth M; Villard L; Milh M
    Epilepsia; 2019 May; 60(5):845-856. PubMed ID: 31026061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SCN8A encephalopathy: Mechanisms and models.
    Meisler MH
    Epilepsia; 2019 Dec; 60 Suppl 3(Suppl 3):S86-S91. PubMed ID: 31904118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. De novo SCN8A and inherited rare CACNA1H variants associated with severe developmental and epileptic encephalopathy.
    Stringer RN; Jurkovicova-Tarabova B; Souza IA; Ibrahim J; Vacik T; Fathalla WM; Hertecant J; Zamponi GW; Lacinova L; Weiss N
    Mol Brain; 2021 Aug; 14(1):126. PubMed ID: 34399820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genotype-phenotype correlations in SCN8A-related disorders reveal prognostic and therapeutic implications.
    Johannesen KM; Liu Y; Koko M; Gjerulfsen CE; Sonnenberg L; Schubert J; Fenger CD; Eltokhi A; Rannap M; Koch NA; Lauxmann S; Krüger J; Kegele J; Canafoglia L; Franceschetti S; Mayer T; Rebstock J; Zacher P; Ruf S; Alber M; Sterbova K; Lassuthová P; Vlckova M; Lemke JR; Platzer K; Krey I; Heine C; Wieczorek D; Kroell-Seger J; Lund C; Klein KM; Au PYB; Rho JM; Ho AW; Masnada S; Veggiotti P; Giordano L; Accorsi P; Hoei-Hansen CE; Striano P; Zara F; Verhelst H; Verhoeven JS; Braakman HMH; van der Zwaag B; Harder AVE; Brilstra E; Pendziwiat M; Lebon S; Vaccarezza M; Le NM; Christensen J; Grønborg S; Scherer SW; Howe J; Fazeli W; Howell KB; Leventer R; Stutterd C; Walsh S; Gerard M; Gerard B; Matricardi S; Bonardi CM; Sartori S; Berger A; Hoffman-Zacharska D; Mastrangelo M; Darra F; Vøllo A; Motazacker MM; Lakeman P; Nizon M; Betzler C; Altuzarra C; Caume R; Roubertie A; Gélisse P; Marini C; Guerrini R; Bilan F; Tibussek D; Koch-Hogrebe M; Perry MS; Ichikawa S; Dadali E; Sharkov A; Mishina I; Abramov M; Kanivets I; Korostelev S; Kutsev S; Wain KE; Eisenhauer N; Wagner M; Savatt JM; Müller-Schlüter K; Bassan H; Borovikov A; Nassogne MC; Destrée A; Schoonjans AS; Meuwissen M; Buzatu M; Jansen A; Scalais E; Srivastava S; Tan WH; Olson HE; Loddenkemper T; Poduri A; Helbig KL; Helbig I; Fitzgerald MP; Goldberg EM; Roser T; Borggraefe I; Brünger T; May P; Lal D; Lederer D; Rubboli G; Heyne HO; Lesca G; Hedrich UBS; Benda J; Gardella E; Lerche H; Møller RS
    Brain; 2022 Sep; 145(9):2991-3009. PubMed ID: 34431999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic and clinical features of SCN8A developmental and epileptic encephalopathy.
    Kim HJ; Yang D; Kim SH; Kim B; Kim HD; Lee JS; Choi JR; Lee ST; Kang HC
    Epilepsy Res; 2019 Dec; 158():106222. PubMed ID: 31675620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NBI-921352, a first-in-class, Na
    Johnson JP; Focken T; Khakh K; Tari PK; Dube C; Goodchild SJ; Andrez JC; Bankar G; Bogucki D; Burford K; Chang E; Chowdhury S; Dean R; de Boer G; Decker S; Dehnhardt C; Feng M; Gong W; Grimwood M; Hasan A; Hussainkhel A; Jia Q; Lee S; Li J; Lin S; Lindgren A; Lofstrand V; Mezeyova J; Namdari R; Nelkenbrecher K; Shuart NG; Sojo L; Sun S; Taron M; Waldbrook M; Weeratunge D; Wesolowski S; Williams A; Wilson M; Xie Z; Yoo R; Young C; Zenova A; Zhang W; Cutts AJ; Sherrington RP; Pimstone SN; Winquist R; Cohen CJ; Empfield JR
    Elife; 2022 Mar; 11():. PubMed ID: 35234610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Astrocyte reactivity in a mouse model of SCN8A epileptic encephalopathy.
    Thompson JA; Miralles RM; Wengert ER; Wagley PK; Yu W; Wenker IC; Patel MK
    Epilepsia Open; 2022 Jun; 7(2):280-292. PubMed ID: 34826216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. De novo mutations of voltage-gated sodium channel alphaII gene SCN2A in intractable epilepsies.
    Ogiwara I; Ito K; Sawaishi Y; Osaka H; Mazaki E; Inoue I; Montal M; Hashikawa T; Shike T; Fujiwara T; Inoue Y; Kaneda M; Yamakawa K
    Neurology; 2009 Sep; 73(13):1046-53. PubMed ID: 19786696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biological concepts in human sodium channel epilepsies and their relevance in clinical practice.
    Brunklaus A; Du J; Steckler F; Ghanty II; Johannesen KM; Fenger CD; Schorge S; Baez-Nieto D; Wang HR; Allen A; Pan JQ; Lerche H; Heyne H; Symonds JD; Zuberi SM; Sanders S; Sheidley BR; Craiu D; Olson HE; Weckhuysen S; DeJonge P; Helbig I; Van Esch H; Busa T; Milh M; Isidor B; Depienne C; Poduri A; Campbell AJ; Dimidschstein J; Møller RS; Lal D
    Epilepsia; 2020 Mar; 61(3):387-399. PubMed ID: 32090326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single amino acid deletion in transmembrane segment D4S6 of sodium channel Scn8a (Nav1.6) in a mouse mutant with a chronic movement disorder.
    Jones JM; Dionne L; Dell'Orco J; Parent R; Krueger JN; Cheng X; Dib-Hajj SD; Bunton-Stasyshyn RK; Sharkey LM; Dowling JJ; Murphy GG; Shakkottai VG; Shrager P; Meisler MH
    Neurobiol Dis; 2016 May; 89():36-45. PubMed ID: 26807988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Novel SCN8A mutation in a case of early-onset infantile epileptic encephalopathy: A Case Report.
    Keshri S; Goel AK; Shah S; Garg AK
    Acta Biomed; 2022 Feb; 92(S1):e2021261. PubMed ID: 35188110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nav1.7-A1632G Mutation from a Family with Inherited Erythromelalgia: Enhanced Firing of Dorsal Root Ganglia Neurons Evoked by Thermal Stimuli.
    Yang Y; Huang J; Mis MA; Estacion M; Macala L; Shah P; Schulman BR; Horton DB; Dib-Hajj SD; Waxman SG
    J Neurosci; 2016 Jul; 36(28):7511-22. PubMed ID: 27413160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Domain II S4-S5 Linker in Nav1.9: A Missense Mutation Enhances Activation, Impairs Fast Inactivation, and Produces Human Painful Neuropathy.
    Han C; Yang Y; de Greef BT; Hoeijmakers JG; Gerrits MM; Verhamme C; Qu J; Lauria G; Merkies IS; Faber CG; Dib-Hajj SD; Waxman SG
    Neuromolecular Med; 2015 Jun; 17(2):158-69. PubMed ID: 25791876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secondary neurotransmitter deficiencies in epilepsy caused by voltage-gated sodium channelopathies: A potential treatment target?
    Horvath GA; Demos M; Shyr C; Matthews A; Zhang L; Race S; Stockler-Ipsiroglu S; Van Allen MI; Mancarci O; Toker L; Pavlidis P; Ross CJ; Wasserman WW; Trump N; Heales S; Pope S; Cross JH; van Karnebeek CD
    Mol Genet Metab; 2016 Jan; 117(1):42-8. PubMed ID: 26647175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Missense variants in the N-terminal domain of the A isoform of FHF2/FGF13 cause an X-linked developmental and epileptic encephalopathy.
    Fry AE; Marra C; Derrick AV; Pickrell WO; Higgins AT; Te Water Naude J; McClatchey MA; Davies SJ; Metcalfe KA; Tan HJ; Mohanraj R; Avula S; Williams D; Brady LI; Mesterman R; Tarnopolsky MA; Zhang Y; Yang Y; Wang X; ; Rees MI; Goldfarb M; Chung SK
    Am J Hum Genet; 2021 Jan; 108(1):176-185. PubMed ID: 33245860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.